SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001828185-24-000058
Filing Date
2024-05-14
Accepted
2024-05-14 16:23:15
Documents
1
Period of Report
2024-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1715718176.html 4  
1 FORM 4 wk-form4_1715718176.xml 4 4177
  Complete submission text file 0001828185-24-000058.txt   5842
Mailing Address 579 BELLEVUE AVE NEWPORT RI 02840
Business Address
DAWES KAREN A (Reporting) CIK: 0001261506 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40367 | Film No.: 24944750

Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Issuer) CIK: 0001828185 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)